Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Harte Hanks (HHS) Depreciation and Depletion (2016 - 2025)

Harte Hanks (HHS) has disclosed Depreciation and Depletion for 12 consecutive years, with $1.2 million as the latest value for Q3 2025.

  • On a quarterly basis, Depreciation and Depletion rose 17.23% to $1.2 million in Q3 2025 year-over-year; TTM through Sep 2025 was $3.7 million, a 6.25% increase, with the full-year FY2024 number at $3.5 million, up 2.94% from a year prior.
  • Depreciation and Depletion was $1.2 million for Q3 2025 at Harte Hanks, up from $393000.0 in the prior quarter.
  • In the past five years, Depreciation and Depletion ranged from a high of $1.2 million in Q3 2025 to a low of $349000.0 in Q4 2023.
  • A 3-year average of $902000.0 and a median of $1.0 million in 2023 define the central range for Depreciation and Depletion.
  • Peak YoY movement for Depreciation and Depletion: fell 1.88% in 2024, then grew 17.23% in 2025.
  • Harte Hanks' Depreciation and Depletion stood at $349000.0 in 2023, then rose by 12.61% to $393000.0 in 2024, then skyrocketed by 209.92% to $1.2 million in 2025.
  • Per Business Quant, the three most recent readings for HHS's Depreciation and Depletion are $1.2 million (Q3 2025), $393000.0 (Q4 2024), and $1.0 million (Q3 2024).